Back to Sculptra Home Page
Many men and women in the New Orleans area want to maintain their youthful appearance. The unwanted signs of aging often start to creep up on the skin after the age of thirty as patients begin to lose their natural stores of collagen and elastin, which keep the skin supple and firm. As skin laxity becomes a problem, so does the development of fine lines and wrinkles, and many patients visit us to learn about non-invasive ways to combat these issues and keep their youth for as long as possible without surgical intervention. Dr. Mary Lupo at the Lupo Center for Aesthetic and General Dermatology may recommend Sculptra treatment.
Sculptra treatment is just one of many options available when it comes to injectable services at our practice. However, Sculptra is not like many of the other dermal fillers used for reducing the depth of fine lines and wrinkles on the face such as Juvéderm, Perlane, and Restylane. Sculptra is made of poly-L lactic acid, and when injected into specific areas of the face, it stimulates the production of collagen. Because this injection helps at the source of the problem, restoring lost collagen, it can provide long-lasting results with fewer injections. Many patients notice their skin looks beautiful and revived over a few months after the first injection, and can enjoy the results for several years.
Dr. Mary Lupo is proud to be on the first physician advisory board to participate in the training and use of Sculptra before it was introduced in the United States in 2004. She continues to be a certified training provider for Sculptra.
If you think Sculptra is the anti-aging solution for you, book an appointment at the Lupo Center for Aesthetic and General Dermatology today. We can make appropriate recommendations for you based on your specific lifestyle, needs, and budget. We want patients to have access to numerous options to enhance their appearance and love the skin they're in!
Avoid these medications for at least two weeks prior to injections: Aspirin or Ibuprofen, Fish Oil, Vitamin E, “G” supplements (ginko, ginseng, garlic), St. John's Wort and non-steroidal anti-inflammatory medications like Celebrex, as they may cause thinning of the blood.
Lupo Center for Aesthetic and General Dermatology
Mary P. Lupo, M.D. - Connect on Linkedin
Our mission at the Lupo Center is to provide patients with innovative, effective, and ethical care to make each person look and feel their personal best. To fulfill our goal, we provide state-of-the-art medical, surgical, and cosmetic treatments to all patients.
Board-certified dermatologist and clinical professor of dermatology Mary P. Lupo, MD, has been a leader in the field of non-surgical rejuvenation since 1983. She travels internationally to teach her innovative techniques, and her reputation brings in patients from around the country. She started the first formal residency training program for injectables and peels in 1983 at Tulane Medical School and served as past president of the Women’s Dermatologic Society, adjunct professor of dermatology at Tulane, and a founder of Cosmetic Boot Camp. Dr. Lupo holds membership in many prestigious dermatology associations, participates in clinical trials for the approval of new drugs and devices, and acts as an advisor for numerous aesthetic-minded companies.
Dr. Lupo was recently recognized as a trailblazer for women in dermatology and for her dedication to educating dermatology residents and fellows.
She has also received the following awards:
- 𝐋𝐢𝐟𝐞𝐭𝐢𝐦𝐞 𝐂𝐚𝐫𝐞𝐞𝐫 𝐄𝐝𝐮𝐜𝐚𝐭𝐨𝐫 𝐀𝐰𝐚𝐫𝐝 from the 𝐃𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧 - Recognizes full-time academicians who have dedicated their careers to educating dermatology residents and fellows;
-
𝐖𝐢𝐥𝐦𝐚 𝐁𝐞𝐫𝐠𝐟𝐞𝐥𝐝, 𝐌𝐃 𝐕𝐢𝐬𝐢𝐨𝐧𝐚𝐫𝐲 and 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐀𝐰𝐚𝐫𝐝 from the 𝐖𝐨𝐦𝐞𝐧'𝐬 𝐃𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐢𝐜 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 - Recognizes dermatologists of national prominence who have been trailblazers for women in some aspect of dermatology.
Dr. Lupo has authored over 90 published articles and book chapters and has spoken on various dermatological topics at nearly 480 national and international meetings and seminars.